Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion | Semantic Scholar
Z0710N Human Kappa Opioid Receptor (OPRK1) | Montana Molecular
Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or approach-avoidance behavior occur differentially across the nucleus accumbens shell rostro-caudal axis - ScienceDirect
κ-Opioid Receptor (KOP) | 7TM Antibodies
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid Agonists | HTML
The blocking of kappa‐opioid receptor reverses the changes in dorsolateral striatum dopamine dynamics during the amphetamine sensitization - Azocar - 2019 - Journal of Neurochemistry - Wiley Online Library
Role of Kappa Opioid Receptors in Symptoms of Schizophrenia: What Is the Neurobiology? - Biological Psychiatry
Top: Distribution of kappa opioid (7-transmembrane receptor), estrogen,... | Download Scientific Diagram
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Kinase cascades and ligand-directed signaling at the kappa opioid receptor | SpringerLink
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - Biological Psychiatry
Regulation of κ-Opioid Receptor Signaling in Peripheral Sensory Neurons In Vitro and In Vivo | Journal of Pharmacology and Experimental Therapeutics
Opioid Receptor | kappa, mu Opioid Receptor
Prolonged Kappa Opioid Receptor Phosphorylation Mediated by G-protein Receptor Kinase Underlies Sustained Analgesic Tolerance* - Journal of Biological Chemistry
Enhancing Remyelination through a Novel Opioid-Receptor Pathway | Journal of Neuroscience
κ-opioid receptor - Wikipedia
Modulation of the kappa and mu opioid axis for the treatment of chronic pruritus: A review of basic science and clinical implications - JAAD International
Mapping the Kappa Opioid Receptor Using RTI's JDTic Compound | RTI
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)